Selective antibacterial activity of patchouli alcohol against Helicobacter pylori based on inhibition of urease.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
patchouli alcohol (PA) | decrease | Helicobacter pylori | selected bacteria and fungi | - | exhibited selective antibacterial activity | #1 |
patchouli alcohol (PA) | no change | major normal gastrointestinal bacteria | selected bacteria and fungi | - | without influencing | #2 |
patchouli alcohol (PA) | increase | antibacterial activity | Helicobacter pylori | minimal inhibition concentration value of 78 µg/mL | superior to that of amoxicillin | #3 |
patchouli alcohol (PA) | decrease | ureases from H.pylori | - | IC50 values of 2.67 ± 0.79 mM | inhibited | #4 |
patchouli alcohol (PA) | decrease | ureases from jack bean | - | IC50 values of 2.99 ± 0.41 mM | inhibited | #5 |
DL-dithiothreitol | decrease | urease | - | - | synergistically inactivated | #6 |
The aim of this study is to evaluate the antibacterial activity and urease inhibitory effects of patchouli alcohol (PA), the bioactive ingredient isolated from Pogostemonis Herba, which has been widely used for the treatment of gastrointestinal disorders. The activities of PA against selected bacteria and fungi were determined by agar dilution method. It was demonstrated that PA exhibited selective antibacterial activity against Helicobacter pylori, without influencing the major normal gastrointestinal bacteria. Noticeably, the antibacterial activity of PA was superior to that of amoxicillin, with minimal inhibition concentration value of 78 µg/mL. On the other hand, PA inhibited ureases from H.pylori and jack bean in concentration-dependent fashion with IC50 values of 2.67 ± 0.79 mM and 2.99 ± 0.41 mM, respectively. Lineweaver-Burk plots indicated that the type of inhibition was non-competitive against H.pylori urease whereas uncompetitive against jack bean urease. Reactivation of PA-inactivated urease assay showed DL-dithiothreitol, the thiol reagent, synergistically inactivated urease with PA instead of enzymatic activity recovery. In conclusion, the selective H.pylori antibacterial activity along with urease inhibitory potential of PA could make it a possible drug candidate for the treatment of H.pylori infection.